CIBC World Markets Inc. lifted its holdings in Mylan (NASDAQ:MYL) by 59.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,935 shares of the company’s stock after buying an additional 22,813 shares during the period. CIBC World Markets Inc.’s holdings in Mylan were worth $2,578,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of MYL. Meeder Asset Management Inc. raised its holdings in shares of Mylan by 76.9% during the third quarter. Meeder Asset Management Inc. now owns 3,393 shares of the company’s stock worth $106,000 after acquiring an additional 1,475 shares in the last quarter. BT Investment Management Ltd purchased a new stake in shares of Mylan during the third quarter worth $142,000. First Personal Financial Services raised its holdings in shares of Mylan by 77.1% during the fourth quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock worth $205,000 after acquiring an additional 2,106 shares in the last quarter. Mycio Wealth Partners LLC purchased a new stake in shares of Mylan during the fourth quarter worth $212,000. Finally, Advisor Partners LLC purchased a new stake in shares of Mylan during the fourth quarter worth $214,000. 75.00% of the stock is owned by institutional investors and hedge funds.
In other news, CEO Heather M. Bresch sold 75,000 shares of Mylan stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total value of $3,375,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.69% of the company’s stock.
Several equities analysts have weighed in on MYL shares. Royal Bank of Canada set a $32.00 target price on Mylan and gave the company a “hold” rating in a report on Friday, October 20th. Mizuho restated a “buy” rating and set a $37.00 target price on shares of Mylan in a report on Tuesday, October 24th. BidaskClub upgraded Mylan from a “hold” rating to a “buy” rating in a report on Friday, October 27th. Cantor Fitzgerald set a $34.00 target price on Mylan and gave the company a “hold” rating in a report on Tuesday, October 31st. Finally, Zacks Investment Research lowered Mylan from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $44.65.
Mylan (NASDAQ MYL) traded up $0.03 during trading on Friday, hitting $39.28. The stock had a trading volume of 6,785,732 shares, compared to its average volume of 5,613,673. The company has a quick ratio of 0.95, a current ratio of 1.46 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $21,071.21, a price-to-earnings ratio of 24.40, a PEG ratio of 1.06 and a beta of 1.35. Mylan has a twelve month low of $29.39 and a twelve month high of $47.82.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.